Mental Health Clinics in Cicero, IL Accepting Medicare
8 Mental Health Clinics found. Showing 1 - 8
 Youth Outreach Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 6117 W Cermak Rd, Cicero, IL 60804 Phone: 773-777-7112 Fax: 708-652-5379 |
Chicago Treatment & Counseling Center #3 Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1849 S Cicero Ave, Cicero, IL 60804 Phone: 708-656-9500 Fax: 708-656-0794 |
Chicago Treatment & Counseling Center #4 Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 5635 W Roosevelt Rd, Cicero, IL 60804 Phone: 708-652-6500 Fax: 708-652-6475 |
Family Service & Mhc Of Cicero At Cicero Health Dept Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 2250 S 49th Ave, Cicero, IL 60804 Phone: 708-656-3600 |
Family Service And Mental Health Center Of Cicero Community/Behavioral Health Agency Medicare: Medicare Enrolled Practice Location: 5341 W Cermak Rd, Cicero, IL 60804 Phone: 708-656-6430 Fax: 708-656-6591 |
West Regional Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1400 S Austin Blvd, Cicero, IL 60804 Phone: 708-329-4026 |
Jimare Wellness Counseling Center Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 5915 W Cermak Rd, Cicero, IL 60804 Phone: 708-391-5505 Fax: 708-433-4441 |
Pilsen Wellness Center, Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1407 S 49th Ct, Cicero, IL 60804 Phone: 708-683-5500 Fax: 708-683-5505 |
News Archive
Clinical studies confirm safety, efficacy of opicapone in Parkinson's disease patients
BIAL is presenting 11 research posters at the 19th International Congress of Parkinson's Disease and Movement Disorders (June 14–15, San Diego, CA). These evaluate the safety and efficacy of opicapone (BIA 9-1067), a novel once-daily catechol-O-methyltransferase (COMT) inhibitor for use as adjunctive therapy in levodopa-treated Parkinson's disease patients with end of dose motor fluctuations.
White House, FDA often experience internal clashes
The internal clashes over F.D.A. policy played out against a broader backdrop of regulatory politics. Republicans have made the charge that Mr. Obama is an overzealous and job-killing regulator -; a central element of their case against his re-election. And on issues from clean air to investor protections, the White House has been carefully calibrating its election season positions.
Treatment for urea cycle disorders proves its worth 25 years later
The simple notion of copying the body's own natural "waste disposal" chemistry to mop up potentially toxic nitrogen has saved an estimated 80 percent of patients with urea cycle disorders -- most of them children, according to a report in the New England Journal of Medicine summarizing a quarter century of experience with the treatment.
Study compares ultrasound versus conventional strategies in early rheumatoid arthritis
Researchers have found that using the information form ultrasound technology in the treatment protocol did not affect the outcome of the patients with Rheumatoid arthritis. The study titled, "Ultrasound versus Conventional Treat-To-Target Strategies in Early Rheumatoid Arthritis: Magnetic Resonance Imaging Outcome Data from a 2-year Randomized Controlled Strategy Trial," was presented at the 2019 ACR/ARP Annual Meeting.
› Verified 3 days ago